Uploaded image for project: 'FHIR Specification Feedback'
  1. FHIR Specification Feedback
  2. FHIR-38811

AdverseEvent - Section 9.9.1

    XMLWordPrintableJSON

Details

    • Change Request
    • Resolution: Persuasive with Modification
    • Highest
    • FHIR Core (FHIR)
    • R5
    • Patient Care
    • AdverseEvent
    • Section 9.9.1
    • Hide

      Add:  In clinical research trials, serious adverse events are usually required to be reported to the respective health authorities (e.g., U.S. FDA)

      Show
      Add:  In clinical research trials, serious adverse events are usually required to be reported to the respective health authorities (e.g., U.S. FDA)
    • Dan Rutz / Rik Smithies : 9-0-1
    • Clarification
    • Non-substantive
    • R5

    Description

      For clinical research, I think it's important to mention that there's a regulatory requirement to communicate serious adverse events (e.g., https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=312.32#:~:text=Adverse%20event%20means%20any%20untoward,life%2Dthreatening%20suspected%20adverse%20reaction.) 

      Verbatim:
      "In the clinical research setting, the event is additionally tracked and evaluated as part of the clinical research process for the research study, since the occurrence of an adverse event may surface a potential confounder or a potential side-effect of the study treatment."

      Addition:
      "In clinical research trials, serious adverse events are required to be reported to the respective health authorities (e.g., U.S. FDA)"

       

       

      Attachments

        Activity

          People

            Unassigned Unassigned
            mhamidi Mike Hamidi
            Watchers:
            2 Start watching this issue

            Dates

              Created:
              Updated:
              Resolved: